Gensight Biologics SA (GSGTF, $0.24) lost over the last three months. By comparison, the broader Biotechnology Industry returned over the same period. A.I.dvisor analyzed 856 stocks in the Biotechnology Industry over the last three months, and found that of them (3) exhibited an Uptrend while of them (6) experienced a Downtrend. A.I.dvisor found 421 similar cases when GSGTF's price dropped within three months. In out of those 421 cases, GSGTF's price went down during the following month. Based on these historical data, A.I. thinks the odds of a Downtrend continuation for GSGTF are